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Abstract 1 
 2 
Background/Aims: Cronobacter spp. have been identified as being of considerable 3 
risk to neonates. The occurrence of organism in infant formulas is therefore of 4 
considerable interest. Methods: The occurrence of Cronobacter spp. in infant feeds 5 
(formulas and fortified cow’s milk) was determined using most probable number 6 
(MPN) analysis, and from formula preparation utensils. Ninety nine samples were 7 
analyzed, of which 42 were unopened cans of powdered infant formula (PIF), 25 8 
reconstituted infant formulas in feeding bottles, 27 utensils used from the preparation 9 
of infant formula, and 5 samples of fortified cow’s milk. Presumptive Cronobacter 10 
spp. isolates were identified using the 7 allele multilocus sequence typing (MLST) 11 
scheme. Results: C. sakazakii, C. malonaticus and C. muytjensii were recovered 12 
from PIF. Although the incidence of Cronobacter in PIF was 29% (12/42), the level 13 
was low with an average of 0.54 MPN/100g. According to MLST profiling, C. 14 
sakazakii was the most frequently isolated Cronobacter species, and C. sakazakii 15 
ST4 (associated with neonatal meningitis) was recovered from 2/42 PIF samples at 16 
0.51 and 0.92 MPN/100g. Conclusions: Cronobacter spp. can be isolated from PIF 17 
and therefore strict hygienic practices during PIF preparation are important to 18 
minimize neonate exposure and reduce the risk of severe infections.   19 
 20 
21 
 3 
Introduction 1 
Cronobacter spp. are Gram-negative bacterial pathogens that cause 2 
meningitis, septicaemia and necrotizing enterocolitis in newborn babies and infants 3 
[1]. Such infections have a high fatality rate of 40 to 80%, and survivors often suffer 4 
from severe neurological disorders [2]. The Cronobacter genus consists of seven 5 
species: C. sakazakii, C. malonaticus, C. muytjensii, C. turicensis, C. dublinensis, C. 6 
universalis, and C. condimenti [3,4]. Cronobacter spp., especially C. sakazakii, have 7 
been implicated in several outbreaks and sporadic cases of diseases involving 8 
mainly neonates [5,6,7]. This may be related to sialic acid metabolism which is only 9 
encoded on the C. sakazakii genome and none of the other six Cronobacter species 10 
[8]. This compound is found in breast milk, intestinal mucin, gangliosides and is 11 
added to powdered infant formula [9,10].   12 
A MLST scheme has been established for the Cronobacter genus which is an 13 
open access database resource (www.pubMLST.org/cronobacter) hosted by the 14 
University of Oxford, UK. It is based on seven housekeeping genes; atpD, fusA, glnS, 15 
gltB, gyrB, infB and ppsA [11,12]. The total concatenated length of the 7 loci is 3036 16 
nucleotides. Currently 136 sequence types (STs) have been identified in the 17 
Cronobacter genus of which 73 sequence types are in C. sakazakii.  Genotyping of 18 
Cronobacter isolates using MLST has revealed that the majority of serious meningitis 19 
clinical cases in neonates over the past 30 years were caused by a single clonal 20 
lineage, clonal complex (CC4) of C. sakazakii and especially sequence type C. 21 
sakazakii ST4 [4,13]. The much publicized Cronobacter cases in the US in 2011 22 
were also C. sakazakii CC4 [6,7].  The reason for the predominance is currently 23 
unclear, though recently it has been reported that a third of Cronobacter isolates 24 
recovered from milk powder processing factories are the C. sakazakii ST4 meningitic 25 
lineage [14]. 26 
Cases of neonatal Cronobacter infections can provoke strong public concern 27 
and despite thorough investigation their source cannot always be identified [6,15].  In 28 
several outbreaks PIF may have been the source of Cronobacter infection [16,17,18]. 29 
These food products are not commercially sterile products and even low 30 
contamination levels by Cronobacter spp. are considered a significant risk factor as 31 
the organism grows rapidly on reconstitution [19,20,21].  Nevertheless the organism 32 
has not been recovered from unopened cans of PIF at levels >1 cfu/g and therefore 33 
 4 
hygienic practices and temperature abuse could considerably increase the risk of 1 
infection. 2 
The source of C. sakazakii ST4 is therefore of considerable interest since 3 
controlling this lineage could reduce neonatal exposure to severe, life-threatening 4 
infections. Although C. sakazakii ST4 has been reported in PIF [11], due to the 5 
common practice of presence/absence testing, it has never been enumerated. 6 
Cronobacter is ubiquitous in the environment and therefore PIF is not the sole route 7 
of exposure or infection [1,22,23]. It has been isolated from the nasogastric feeding 8 
tubes of neonates not exposed to infant formula [24]. Therefore an informed 9 
assessment of neonatal exposure warrants further investigation for the prevalence of 10 
Cronobacter spp., especially CC4, in PIF and other sources. Previous studies of 11 
hospital practices following Cronobacter outbreaks have shown that equipment used 12 
for formula reconstitution and feeding practices can be significant risk factors 13 
[25,26,27,28]. 14 
Current Cronobacter detection methods use a pre-enrichment step in their 15 
initial isolation and therefore the organism is not enumerated in the sample. Given 16 
the importance of controlling neonatal exposure to the bacterium, this study used the 17 
most probable number (MPN) approach to enumerate the organism. In order to 18 
obtain a greater perspective on the routes of exposure to the bacterium in the 19 
hospital environment, the study included fortified cow’s milk in infant feeding bottles 20 
and formula preparation equipment collected from three hospitals. This study has 21 
incorporated the recent taxonomic revisions to the Cronobacter genus, and the 22 
establishment of MLST for Cronobacter speciation and genotyping [4]. 23 
24 
 5 
Materials and methods 1 
 2 
Sample collection  3 
Prepared infant feeds were obtained from four maternity hospitals. PIF samples 4 
were those commercially available in the city of Campinas (San Paulo, Brazil). In 5 
total, 99 samples were tested. This consisted of 14 PIF samples for premature or 6 
underweight newborn infants, 15 PIF for target age 0 to 6 months, 7 follow on 7 
formulas (target age 6 months to 1 year) and 6 PIF for nursing infants up to 1 year. 8 
The non-PIF samples from four hospitals were reconstituted infant formula in feeding 9 
bottles (n=25), bottles containing thickened cow’s milk (n=5), used feeding bottles 10 
(n=7), bottle brushes (n=5), dosing cup (n=3), bottle storage (n=4) and blenders 11 
(n=8).  12 
 13 
Isolation of Cronobacter and Enterobacteriaceae  14 
Five hundred grams of each powdered formula, and 200 ml of each 15 
reconstituted infant formula and thickened cow’s milk were analysed in 100g and 40 16 
ml volumes appropriately. Samples were pre-enriched overnight at 37°C in buffered 17 
peptone water, before enrichment in modified lysine tryptose broth (with vancomycin 18 
(mLST-V). Preparation equipment was swabbed and used to inoculate 5ml mLST-V.  19 
Samples were analysed according to the BAX®-PCR System (DuPont Qualicon) 20 
included an additional cultivation in BHI broth at 37oC for three hours before 21 
genotyping.  22 
 23 
Identification of Cronobacter isolates.  24 
Presumptive Cronobacter isolates were subcultured on TSA (25°C, 48-72h) 25 
before phenotypic identification using API20E and ID32E (BioMerieux-Brazil). 26 
Cronobacter species was assigned and the strains further profiled according to the 7 27 
allele MLST scheme with reference to the open access database 28 
(http://www.pubMLST.org/cronobacter) [4,12]. 29 
30 
 6 
Results and Discussion  1 
 2 
Recovery of Cronobacter spp. 3 
From a total of 42 PIF samples, 12 (29%) contained Cronobacter species; 4 
Table 1. The Cronobacter positive samples were PIF formulas from all infant age 5 
groups. In quantitative terms, the most frequent count was 0.51 MPN/100g with a 6 
mean of 0.54 MPN/100g. The highest value determined was 1.61 MPN/100g, which 7 
was found in a sample of formula for premature and/or underweight newborn infants. 8 
No Cronobacter spp. were isolated from the infant formula product designated for 9 
nursing infants up to 1 year in age. Cronobacter spp. were not recovered from any of 10 
the reconstituted infant formulas or fortified cow’s milk samples collected from 11 
hospital nurseries and formula preparation units. Two hospitals used sterile water at 12 
room temperature to reconstitute powdered formula, and a third hospital used hot 13 
water (>70°C). Additionally, no Cronobacter species were detected on the utensils, 14 
brushes or empty feeding bottles collected from the hospitals.  15 
 16 
Genotyping and phenotyping of Cronobacter isolates 17 
Twelve PIF isolates were presumptively identified as being Enterobacter 18 
sakazakii (the former name for the Cronobacter genus) using API 20E and BAX® 19 
(Table 2). The ID32E phenotyping identified the strains as E. sakazakii except the C. 20 
muytjensii isolate (895) which was misidentified as Pantoea spp.  The bioMerieux 21 
and DuPont Qualicon databases do not recognize the Cronobacter genus and were 22 
unable to identify the individual Cronobacter species. Eight strains were further 23 
analyzed using MLST (Table 2). Of these eight strains, six were identified using 24 
MLST as C. sakazakii, and the other two were C. malonaticus and C. muytjensii.  25 
Three of the six C. sakazakii strains were ST4, and had been isolated from follow on 26 
formulas for infants aged 6-12 months. No Cronobacter spp. were isolated from the 27 
infant formula product designated for nursing infants up to 1 year in age. 28 
 29 
Isolation of other Enterobacteriaceae 30 
Enterobacteriaceae other than Cronobacter were isolated from PIF samples. 31 
Two (out of 15) PIF products for infants aged 0 to 6 months contained Pantoea spp., 32 
Escherichia vulneris and Enterobacter cloacae.  All seven follow on formulas 33 
contained Enterobacteriaceae, including Pantoea spp., Enterobacter amnigenus, 34 
 7 
Klebsiella oxytoca, Serratia rubidaea, and Pasteurella pneumotropical/haemolytica.  1 
No Enterobacteriaceae were isolated from the 57 non-PIF samples. 2 
Following the three FAO/WHO risk assessments [29,30,31], the Codex 3 
Alimentarius Commission [32,33] now recommends the absence of Cronobacter in 4 
PIF for infants less than 6 months in age, but this criterion is not applied to PIF 5 
products with intended use by older infants. Contamination of PIF, powdered infant 6 
drinks or other infant foods with Cronobacter spp. can occur during post-7 
pasteurization processing, via the addition of dry ingredients as vitamins and 8 
minerals, or during packaging [34]. Unfortunately very few studies have enumerated 9 
the organism.  Muytjens et al. [35] isolated Cronobacter from 20 of 141 (14.2%) PIF 10 
samples from 35 countries, and the highest concentration was <1 MPN/g. It is 11 
interesting to consider the levels post-2004 following the raised awareness and 12 
increased control of the organism.  In this study Cronobacter spp. were detected in 13 
29% (12/42) of PIF samples, yet none were >2 MPN/100g (Tables 1 and 2).  14 
Edelson-Mammel et al. [36] also reported that the concentration of presence of 15 
Cronobacter in US manufactured PIF was frequently below 1 MPN/100g, 16 
corroborating the results of the present study.  Oonaka et al. [37] in Japan analyzed a 17 
total of 149 samples, of which 61 were of domestic production and 88 imported 18 
samples. Enterobacteriaceae were isolated from 36 (24.2%) samples. Nine (6%) of 19 
these, 4 domestic samples and 5 imported samples, were positive for Cronobacter 20 
spp. and the level was 0.36 - 91 MPN/100g. Palcich et al. [28] analyzed 186 PIF 21 
samples from Brazil with target age of infant 0-6 months in age. Cronobacter spp. 22 
and other Enterobacteriaceae were <0.03 MPN/100g and <5 MPN/g, respectively.   23 
These recent studies however did not identify the Cronobacter species or genotype. 24 
The presence of Cronobacter spp. in follow on formula has not been so well 25 
documented in part due to the lack of a regulatory requirement for a microbiological 26 
criterion, and also because in some countries follow on formula as a defined product 27 
does not exist on the market.   Chap et al. [38] analyzed infant formulas from 7 28 
countries, of which 136 were follow on formulas, and 179 were other infant products. 29 
Cronobacter spp. was isolated from 1 sample of infant follow on formula (1%), and 22 30 
(12%) of other infant products. However the level of Cronobacter was not determined 31 
due to the non-quantitative presence/absence testing of 25g quantities.  32 
The presence of Cronobacter spp. in PIF is considered to be a risk due to the 33 
potential for multiplication of the microorganism in the reconstituted product. The 34 
 8 
ingested level will be dependant on the time and temperature of cooling, storage, 1 
handling and preparation before consumption [31,39].  Hygienic practices including 2 
the control of the time/temperature regimes for the preparation of reconstituted 3 
formulae are important to minimize the risk of contamination and development 4 
microbial biofilms. Neonatal infections can be associated with the colonization of 5 
formula preparation equipment such as brushes, blenders and spoons by 6 
Cronobacter [16,25]. However in this study no Cronobacter or other 7 
Enterobacteriaceae were isolated from hospital equipment demonstrating a good 8 
level of hygiene control.   9 
Cronobacter spp. are not the only Enterobacteriaceae isolated from PIF. The 10 
FAO/WHO [29,30] recommended that research should be undertaken to ascertain 11 
the presence of other Enterobacteriaceae in PIF. These organisms were termed 12 
‘Category B; plausible causing infections, but without supporting epidemiological 13 
evidence’ by the expert committees. In this study the Enterobacteriaceae isolated 14 
from PIF were Pantoea spp., Leclercia adecarboxylata, Klebsiella oxytoca, Serratia 15 
rubidaea, S. plymuthica, and  Pasteurella pneumotropical/haemolytica. E. cloacae, 16 
Pantoea spp. and Klebsiella have been associated with neonatal infections, however 17 
to date no NICU outbreaks have been attributed to this organisms through the 18 
consumption of reconstituted PIF.  Nevertheless such surveillance data has been 19 
requested by FAO/WHO [29].  20 
Discrepancies have previously been reported between the two phenotyping 21 
kits API20E and ID32E, both manufactured by bioMerieux with online databases 22 
[5,40].  Various other examples exist in the literature of organisms which have been 23 
mis-identified as Cronobacter [1,41]. Previously Baldwin et al. [11] demonstrated that 24 
using phenotyping to speciate Cronobacter isolates based on biotype was flawed as 25 
some biotype index strains had been assigned the incorrect Cronobacter species.  26 
As can be seen in Table 2, the biochemical profiles did not correspond with any 27 
particular Cronobacter species, or sequence type. Therefore phenotyping has limited 28 
value for profiling Cronobacter strains, and cannot be used to assign the isolate to 29 
any particular species within the Cronobacter genus, whereas the DNA sequence 30 
based MLST method is reliable and portable due to the open access database. 31 
Phylogenetic analysis showed the majority of isolates were C. sakazakii which 32 
corresponds with previous studies on prevalence [Fig 1]. Three of the six C. 33 
sakazakii strains were in the ST4 lineage which has a strong association with 34 
 9 
neonatal meningitis and therefore a cause for concern [7,13]. Another isolated C. 1 
sakazakii strain was ST1.  This is the same lineage as C. sakazakii BAA-894 which 2 
was isolated from the fatal Tennessee neonatal intensive care unit outbreak in 2001 3 
and the genome of which has been sequenced [18,42]. The remaining C. sakazakii 4 
isolates were in sequence types which have not been linked to neonatal infections. 5 
However it is of interest to note that strains 892 and 894 (ST56 and ST113) were 6 
isolated from PIF for different age groups yet only differ in 2/3036 nucleotides. These 7 
were in the fusA loci (position 135 T:G and position 372 T:C; 8 
www.pubMLST.org/cronobacter). Therefore these strains are in the same clonal 9 
complex, CC11. Whether the PIFs were from the same manufacturer or had common 10 
ingredients is unknown. C. malonaticus was also isolated from one PIF sample for 11 
intended infant age 0-6months. This species has not been associated with neonatal 12 
outbreaks, but is more associated with adult infections [13]. The relevance of 13 
isolating C. muytjensii from PIF, with intended age of use 6-12 months, is uncertain 14 
as to date this species has not been associated with infant infections.   Given that the 15 
two Cronobacter species C. universalis and C. condimenti were only formally 16 
recognized in 2011, previous PCR-based and MALDI-TOF detection methods for 17 
Cronobacter species may be inaccurate as reported by Cetinkaya et al. [43]. Hence 18 
the usefulness of the open access curated MLST database 19 
(www.pubMLST.org/cronobacter) which uses phylogeny to distinguish between the 20 
Cronobacter species and related organisms [4,12]. This level of discrimination and 21 
analysis is not available with previous genotyping methods for Cronobacter spp., 22 
such as pulsed-field gel electrophoresis and serotyping [44,45].  23 
Although Cronobacter spp. are ubiquitous in the environment and therefore a 24 
source of neonatal exposure, it is evident that preventative measures in the 25 
preparation of infant feed are prudent to reduce neonatal exposure to this organism. 26 
Although in this study C. sakazakii ST4 and ST1 were not isolated from PIF intended 27 
for consumption by infants 0-6 months in age, nevertheless they were in follow on 28 
formula and represent a particularly severe, life-threatening form of Cronobacter 29 
infection. These two C. sakazakii sequence types were previously reported to be 30 
frequently (24 and 19% respectively) isolated from milk processing facilities [14]. The 31 
low level (<2 MPN/100g) of the organism in PIF and the lack of recovery from the 32 
hospital facilities probably reflects the microbiological monitoring by the PIF 33 
manufacturers and good hygienic practices in the hospitals.  34 
 10 
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Tables 1 
 2 
 3 
Table 1.  4 
 5 
Most probable number (MPN) enumeration of Cronobacter spp. in powdered infant 6 
formula for various infant age groups 7 
 8 
 9 
Product intended age group 
Number of 
samples analysed 
Number of positive 
samples 
Most probable number 
(MPN/100g) 
Premature and/or underweight 
newborn infants 
14 3 1.61, 0.51, 0.22 
0 to 6 months old children  15 3 0.51, 0.22, 0.22 
6 months to 1 year old children  7 6 
0.92, 0.51, 0.51, 0.51, 
0.51, 0.22 
PIF for nursing infants up to 1 year 6 0 <0.22 
Total 42 12  
 10 
 11 
 12 
 13 
 14 
15 
 15 
 1 
Table 2.  2 
 3 
Identification of Cronobacter isolates from PIF samples 4 
 5 
 6 
 7 
a % match 8 
 9 
b bioMerieux and BAX®-PCR databases give the former taxonomic name of 10 
Enterobacter sakazakii instead of Cronobacter genus. 11 
 12 
c ST = Sequence type    13 
 14 
d UA = Unacceptable profile 15 
 16 
 17 
 18 
19 
Strain 
PIF intended 
age (months) 
Isolate identification 
API 20E  
(biochemical profile, %a) 
ID32E  
 (biochemical profile, %) 
BAX®-PCR MLST (ST)c 
894 0-6 
E. sakazakiib 
(3305373, 98.4) 
E. sakazakii  
(34274767050, 99.9) 
E. sakazakii C. sakazakii (113) 
893 0-6 
E. sakazakii  
(3207173, 96.8) 
E. sakazakii  
(34274763251, 99.9) 
E. sakazakii C. malonaticus (7) 
890 6-12 
E. sakazakii  
(3305373, 98.4) 
E. sakazakii  
(34274767050, 99.9) 
E. sakazakii C. sakazakii (4) 
891 6-12 
E. sakazakii  
(3305373, 98.4) 
E. sakazakii  
(34276367250, 99.9) 
E. sakazakii C. sakazakii (4) 
892 6-12 
E. sakazakii  
(3305373, 98.4) 
E. sakazakii  
(34274767250, 99.9) 
E. sakazakii C. sakazakii (56) 
895 6-12 
E. sakazakii  
(3305373, 98.4) 
Pantoea spp. 
(00074703400, UA)d 
E. sakazakii C. muytjensii 
896 6-12 
E. sakazakii  
(3305373, 99.9) 
E. sakazakii  
(34274767250, 99.9) 
E. sakazakii C. sakazakii (4) 
897 6-12 
E. sakazakii  
(3305173, 51.2) 
E. sakazakii  
(34276763250, 99.9) 
E. sakazakii C. sakazakii (1) 
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Figure 1. Maximum likelihood tree of the seven multilocus sequence typing loci (3036 1 
base pair concatenated length) for the Cronobacter genus, showing the sequence 2 
type for strains isolated from PIF and type strains for the remaining Cronobacter 3 
species. The tree was drawn using MEGA5 (http://www.megasoftware.net/) with 4 
1000 bootstrap replicates.  5 
 6 
 7 
 8 
 9 
 10 
